Ketamine-induced changes in metabolic and endocrine parameters of normal and 2-kidney 1-clip rats

European Journal of Anaesthesiology

Volumn 22, Issue 11, 2005, Pages 875-878

  Saranteas, T ^a,b   Zotos, N ^c   Chantzi, C ^b   Mourouzis, C ^a   Rallis, G ^a   Anagnostopoulou, S ^a   Tesseromatis, C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KAT HOSPITAL   (Greece)

^c UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Anaesthetics, intravenous, ketamine; Angiotensins; Atrial natriuretic factor; Fatty acids nonesterified; Lipids; Renin angiotensin system

Indexed keywords

ATRIAL NATRIURETIC FACTOR; FATTY ACID; KETAMINE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ENDOCRINE FUNCTION; ENZYME ACTIVITY; HEART LEFT VENTRICLE; KIDNEY; LIPID METABOLISM; MALE; NONHUMAN; RAT;

ADIPOSE TISSUE; ANESTHETICS, DISSOCIATIVE; ANGIOTENSIN II; ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; FATTY ACIDS, NONESTERIFIED; HYPERTENSION, RENOVASCULAR; KETAMINE; KIDNEY; LIPID METABOLISM; LIPOPROTEIN LIPASE; MALE; RATS; RATS, WISTAR; RENAL ARTERY; RENIN-ANGIOTENSIN SYSTEM;

EID: 28444454922     PISSN: 02650215     EISSN: 02650215     Source Type: Journal    
DOI: 10.1017/S0265021505001481     Document Type: Article

References (24)

1. Vallottori MB. The renin-angiotensin system. Trend Pharmacol Sci 1987; 8: 69-74.
2. Kagiyama S, Varela A, Phillips I, Galli M. Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats. Hypertension 2001; 37(Part 2): 371-375.
3. Cogan MG. Atrial natriuretic peptide. Kidney Int 1990; 37: 1148-1160.
4. Bartel S, Hoch B, Vetter D, Krause EG. Expression of human angiotensinogen-renin in rat. Effects on transcription and heart function. Hypertension 2002; 39: 219-223.
5. Disuza SE, Davis M, Baxter CF. Autocrine and paracrine action of antidiuretic peptide in the heart. Pharmacol Ther 2004; 101: 113-129.
6. Schorr U, Blasche K, Turan S, Distler A, Sharma AM. Relationship between angiotensinogen, leptin and blood pressure in young normotensive men. J Hypertens 1998; 16: 1475-1480.
7. Moro C, Crampes F, Sengenes C et al. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J 2004; 18: 908-910.
8. Leiter LA, Lewanczuk RZ. Of the renin-angiotensin system and reactive oxygen species: type 2 diabetes and angiotensin II inhibition. Am J Hypertens 2005; 18: 121-128.
9. Galitzky J, Sengenes C, Thalamas C et al. The lipid-mobilizing effect of arterial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J Lipid Res 2001; 42: 536-544.
10. White PF, Way WL, Trevor AJ. Ketamine - its pharmacology and therapeutic uses. Anesthesiology 1982; 56: 119-136.
11. Stoelting KR. Nonbarbiturate induction drugs. In: Stoelting KR, ed. Pharmacology and Physiology in Anesthetic Practice. Philadelphia: Lippincott Williams & Wilkins, 1999: 148-154.
12. Flecknell PA. Anaesthesia. In: Tuffery AA, ed. Laboratory Animals - An Introduction for Experiments. London: John Wiley and Sons, 1995: 325.
13. A receptor activation. Acta Anaesthesiol Scand 2003; 47: 284-290.
14. Saranteas T, Lolis E, Mourouzis C, Potamianou A, Tesseromatis C. Effect of losartan on insulin plasma concentrations and LPL-activity in adipose tissue of hypertensive rats. Horm Metab Res 2003; 35: 164-168.
15. Rule DC, Andersen MK, Balley JW, Swain L, Ficek SJ, Thomas P. Frozen storage of ovine and rats tissues adversely affects lipoprotein lipase activity. J Nutr Biochem 1996; 7: 577-581.
16. Nagase M, Anto K, Katsuyki A et al. Role of natriuretic peptide receptor type C in Dahl-Salt-Sensitve hypertensive rats. Hypertension 1997; 30: 177-185.
17. Pantos C, Davos C, Carageorgiou H, Varonos D, Cokkinos D. Ischaemic preconditioning protects against myocardial dysfunction caused by ischaemia in isolated hypertrophied hearts. Basic Res Cardiol 1996; 91: 444-449.
18. Saavedra JM. Brain and pituitary angiotensin. Endocr Rev 1992; 13: 329-380.
19. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998; 83: 1182-1191.
20. Levin ER, Gender DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
21. Focaccio A, Volpe M, Ambrasio G, Lembo G, Pannain S, Rubattu S. Angiotensin II directly stimulates release of atrial natriuretic factor in isolated rabbit hearts. Circulation 1993; 87: 192-198.
22. Carlsson PO. The renin-angiotensin system in the endocrine pancreas. JOP 2001; 2: 26-32.
23. Jeandel L, Okamura H, Belles-Isles M et al. Immunocytochemical localization, binding, and effects of atrial natriuretic peptide in rats adipocytes. Mol Cell Endocrinol 1988; 62: 69-78.
24. Saranteas T, Zotos N, Lolis E et al. Mechanisms of ketamine action on lipid metabolism in rats. Eur J Anaesth 2005; 22: 222-226.